High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world.

Pérez, Ana Belén

High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world. [electronic resource] - Journal of hepatology 11 2019 - 876-888 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1600-0641

10.1016/j.jhep.2019.06.022 doi


Anilides--therapeutic use
Antiviral Agents--pharmacology
Benzimidazoles--therapeutic use
Carbamates--therapeutic use
Cyclopropanes--therapeutic use
Drug Resistance, Viral--genetics
Drug Therapy, Combination
Female
Fluorenes--therapeutic use
Genotype
Hepacivirus--genetics
Hepatitis C--drug therapy
Humans
Imidazoles--therapeutic use
Lactams, Macrocyclic--therapeutic use
Male
Middle Aged
Proline--analogs & derivatives
Prospective Studies
Pyrrolidines
Retreatment
Ribavirin--therapeutic use
Ritonavir--therapeutic use
Sofosbuvir--therapeutic use
Spain--epidemiology
Sulfonamides--therapeutic use
Sustained Virologic Response
Valine--analogs & derivatives
Viral Nonstructural Proteins--antagonists & inhibitors